Additionally, MAGE-C3 showed varying expression levels across different cancer types, with significantly higher expression in glioblastoma multiforme (GBM), Head and Neck Squamous Cell Carcinoma (HNSC), and Thyroid Carcinoma (THCA), as well as moderate levels in several other malignancies. This evidence concerns the gene MAGEC3 and head and neck squamous cell carcinoma.